Colorectal Cancer | Clinical

Venook Compares the Data Behind Treatment Decisions in Relapsed/Refractory Metastatic CRC

January 11, 2022

During a Targeted Oncology Case-Based Roundtable event, Alan Venook, MD, professor of medicine at the University of California, San Francisco, discussed the data related to regorafenib therapy for relapsed/refractory metastatic colorectal cancer.